Liposomal daunorubicincytarabine for Acute Myeloid Leukaemia (AML)

Regular price £0.00

Tax included.

Daunorubicin and cytarabine are two chemotherapy drugs that have been used as a first treatment for acute myeloid leukaemia (AML) for a long time. Liposomal daunorubicin-cytarabine is a new ‘drug delivery system’ which combines daunorubicin and cytarabine within a tiny fat droplet called a liposome.

Please note - this is a digital download only and you will not receive a hardcopy through the post. 

All our information is available free of charge to people affected by leukaemia and associated conditions. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can. 

Add donation

>